144 related articles for article (PubMed ID: 16641432)
1. Proteomic study of peptide deformylase inhibition in Streptococcus pneumoniae and Staphylococcus aureus.
Wang W; White R; Yuan Z
Antimicrob Agents Chemother; 2006 May; 50(5):1656-63. PubMed ID: 16641432
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics/Pharmacodynamics of Peptide Deformylase Inhibitor GSK1322322 against Streptococcus pneumoniae, Haemophilus influenzae, and Staphylococcus aureus in Rodent Models of Infection.
Hoover J; Lewandowski T; Straub RJ; Novick SJ; DeMarsh P; Aubart K; Rittenhouse S; Zalacain M
Antimicrob Agents Chemother; 2016 Jan; 60(1):180-9. PubMed ID: 26482300
[TBL] [Abstract][Full Text] [Related]
3. Structural variation and inhibitor binding in polypeptide deformylase from four different bacterial species.
Smith KJ; Petit CM; Aubart K; Smyth M; McManus E; Jones J; Fosberry A; Lewis C; Lonetto M; Christensen SB
Protein Sci; 2003 Feb; 12(2):349-60. PubMed ID: 12538898
[TBL] [Abstract][Full Text] [Related]
4. Structures of Staphylococcus aureus peptide deformylase in complex with two classes of new inhibitors.
Lee SJ; Lee SJ; Lee SK; Yoon HJ; Lee HH; Kim KK; Lee BJ; Lee BI; Suh SW
Acta Crystallogr D Biol Crystallogr; 2012 Jul; 68(Pt 7):784-93. PubMed ID: 22751663
[TBL] [Abstract][Full Text] [Related]
5. Commercial broth microdilution panel validation and reproducibility trials for NVP PDF-713 (LBM 415), a novel inhibitor of bacterial peptide deformylase.
Fritsche TR; Moet GJ; Jones RN
Clin Microbiol Infect; 2004 Sep; 10(9):857-60. PubMed ID: 15355422
[TBL] [Abstract][Full Text] [Related]
6. Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae.
Min S; Ingraham K; Huang J; McCloskey L; Rilling S; Windau A; Pizzollo J; Butler D; Aubart K; Miller LA; Zalacain M; Holmes DJ; O'Dwyer K
Antimicrob Agents Chemother; 2015 Aug; 59(8):4644-52. PubMed ID: 26014938
[TBL] [Abstract][Full Text] [Related]
7. Formyl peptide receptor-mediated proinflammatory consequences of peptide deformylase inhibition in Staphylococcus aureus.
Mader D; Rabiet MJ; Boulay F; Peschel A
Microbes Infect; 2010 May; 12(5):415-9. PubMed ID: 20156579
[TBL] [Abstract][Full Text] [Related]
8. Structure analysis of peptide deformylases from Streptococcus pneumoniae, Staphylococcus aureus, Thermotoga maritima and Pseudomonas aeruginosa: snapshots of the oxygen sensitivity of peptide deformylase.
Kreusch A; Spraggon G; Lee CC; Klock H; McMullan D; Ng K; Shin T; Vincent J; Warner I; Ericson C; Lesley SA
J Mol Biol; 2003 Jul; 330(2):309-21. PubMed ID: 12823970
[TBL] [Abstract][Full Text] [Related]
9. Quality control guidelines for MIC susceptibility testing of NVP PDF-713: a novel peptide deformylase inhibitor.
Anderegg TR; Biedenbach DJ; Jones RN;
Int J Antimicrob Agents; 2003 Jul; 22(1):84-6. PubMed ID: 12842335
[No Abstract] [Full Text] [Related]
10. Potent sub-MIC effect of GSK1322322 and other peptide deformylase inhibitors on in vitro growth of Staphylococcus aureus.
Butler D; Chen D; O'Dwyer K; Lewandowski T; Aubart K; Zalacain M
Antimicrob Agents Chemother; 2014; 58(1):290-6. PubMed ID: 24165188
[TBL] [Abstract][Full Text] [Related]
11. Determination of disk diffusion and MIC quality control ranges for GSK1322322, a novel peptide deformylase inhibitor.
Ross JE; Scangarella-Oman NE; Miller LA; Sader HS; Jones RN
J Clin Microbiol; 2011 Nov; 49(11):3928-30. PubMed ID: 21918031
[TBL] [Abstract][Full Text] [Related]
12. Discovery of piperazic acid peptide deformylase inhibitors with in vivo activity for respiratory tract and skin infections.
Spletstoser JT; Dreabit J; Knox AN; Benowitz A; Campobasso N; Ward P; Cui G; Lewandowski T; McCloskey L; Aubart KM
Bioorg Med Chem Lett; 2019 Aug; 29(16):2410-2414. PubMed ID: 31160176
[TBL] [Abstract][Full Text] [Related]
13. Peptide deformylase as an antibacterial drug target: target validation and resistance development.
Apfel CM; Locher H; Evers S; Takács B; Hubschwerlen C; Pirson W; Page MG; Keck W
Antimicrob Agents Chemother; 2001 Apr; 45(4):1058-64. PubMed ID: 11257016
[TBL] [Abstract][Full Text] [Related]
14. Resistance of Streptococcus pneumoniae to deformylase inhibitors is due to mutations in defB.
Margolis P; Hackbarth C; Lopez S; Maniar M; Wang W; Yuan Z; White R; Trias J
Antimicrob Agents Chemother; 2001 Sep; 45(9):2432-5. PubMed ID: 11502510
[TBL] [Abstract][Full Text] [Related]
15. Antipneumococcal activity of LBM415, a new peptide deformylase inhibitor, compared with those of other agents.
Ednie LM; Pankuch G; Appelbaum PC
Antimicrob Agents Chemother; 2004 Oct; 48(10):4027-32. PubMed ID: 15388472
[TBL] [Abstract][Full Text] [Related]
16. Identification of novel potent bicyclic peptide deformylase inhibitors.
Molteni V; He X; Nabakka J; Yang K; Kreusch A; Gordon P; Bursulaya B; Warner I; Shin T; Biorac T; Ryder NS; Goldberg R; Doughty J; He Y
Bioorg Med Chem Lett; 2004 Mar; 14(6):1477-81. PubMed ID: 15006385
[TBL] [Abstract][Full Text] [Related]
17. Co-crystallization of Staphylococcus aureus peptide deformylase (PDF) with potent inhibitors.
Harris MS; Bock JH; Choi G; Cialdella JS; Curry KA; Deibel MR; Jacobsen EJ; Marshall VP; Murray RW; Vosters AF; Wolfe CL; Yem AW; Baldwin ET
Acta Crystallogr D Biol Crystallogr; 2002 Dec; 58(Pt 12):2153-6. PubMed ID: 12454484
[TBL] [Abstract][Full Text] [Related]
18. In vitro antibacterial activity of the peptide deformylase inhibitor BB-83698.
Lofland D; Difuntorum S; Waller A; Clements JM; Weaver MK; Karlowsky JA; Johnson K
J Antimicrob Chemother; 2004 Apr; 53(4):664-8. PubMed ID: 14973152
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial spectrum and activity of NVP PDF-713, a novel peptide deformylase inhibitor, tested against 1,837 recent Gram-positive clinical isolates.
Jones RN; Fritsche TR; Sader HS
Diagn Microbiol Infect Dis; 2004 May; 49(1):63-5. PubMed ID: 15135503
[TBL] [Abstract][Full Text] [Related]
20. Peptide deformylase inhibitors with activity against respiratory tract pathogens.
East SP; Beckett RP; Brookings DC; Clements JM; Doel S; Keavey K; Pain G; Smith HK; Thomas W; Thompson AJ; Todd RS; Whittaker M
Bioorg Med Chem Lett; 2004 Jan; 14(1):59-62. PubMed ID: 14684298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
